Both in Pharmaceuticals
Prelude Therapeutics Incorporated vs Canopy Growth
Over the past year PRLD returned +144.0% and CGC returned −47.4%; their daily moves had a correlation of 0.11.
PRLD +144.0% CGC −47.4%Growth of $1, one year, split-adjusted
| Metric | PRLD | CGC |
|---|---|---|
| Price | $3.88 | $0.6525 |
| Market cap | $309.6M | $276.0M |
| Today | −5.37% | −3.33% |
| 1 month | +2.4% | −26.1% |
| 6 months | −17.4% | −42.3% |
| Year to date | +33.8% | −42.8% |
| 1 year | +145.6% | −47.8% |
| Revenue growth (YoY) | — | +7.8% |
| Gross margin | 100.0% | 27.4% |
| Net margin | −244.1% | −18.0% |
| P/E (TTM) | — | — |
| Price / sales | 13.8× | 1.1× |
| Net cash | $151.8M | $67.9M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 40.8% |
| Short % of float | 13.2% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).